Open AccessSGLT-2 inhibitors as potential anticonvulsants: empagliflozin, but not dapagliflozin, renders a pronounced effect and potentiates the sodium valproate activity in pentylenetetrazole-induced seizures
Author(s) -
Vadim Tsyvunin,
S. Yu. Shtrygol,
I. O. Havrylov,
Diana Shtrygol,
Artur Reus
Publication year - 2022
Publication title -
sciencerise. pharmaceutical science
Language(s) - English
Resource type - Journals
eISSN - 2519-4852
pISSN - 2519-4844
DOI - 10.15587/2519-4852.2022.266065
Subject(s) - empagliflozin , dapagliflozin , anticonvulsant , pharmacology , epilepsy , medicine , sodium , chemistry , endocrinology , diabetes mellitus , organic chemistry , psychiatry , type 2 diabetes , type 2 diabetes mellitus